1. Home
  2. MRSN vs INDO Comparison

MRSN vs INDO Comparison

Compare MRSN & INDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRSN
  • INDO
  • Stock Information
  • Founded
  • MRSN 2001
  • INDO 2018
  • Country
  • MRSN United States
  • INDO Indonesia
  • Employees
  • MRSN N/A
  • INDO N/A
  • Industry
  • MRSN Biotechnology: Pharmaceutical Preparations
  • INDO Oil & Gas Production
  • Sector
  • MRSN Health Care
  • INDO Energy
  • Exchange
  • MRSN Nasdaq
  • INDO Nasdaq
  • Market Cap
  • MRSN 37.0M
  • INDO 41.5M
  • IPO Year
  • MRSN 2017
  • INDO 2019
  • Fundamental
  • Price
  • MRSN $7.15
  • INDO $2.91
  • Analyst Decision
  • MRSN Strong Buy
  • INDO
  • Analyst Count
  • MRSN 3
  • INDO 0
  • Target Price
  • MRSN $33.00
  • INDO N/A
  • AVG Volume (30 Days)
  • MRSN 62.6K
  • INDO 313.8K
  • Earning Date
  • MRSN 11-12-2025
  • INDO 10-24-2025
  • Dividend Yield
  • MRSN N/A
  • INDO N/A
  • EPS Growth
  • MRSN N/A
  • INDO N/A
  • EPS
  • MRSN N/A
  • INDO N/A
  • Revenue
  • MRSN $34,769,000.00
  • INDO $2,667,508.00
  • Revenue This Year
  • MRSN N/A
  • INDO N/A
  • Revenue Next Year
  • MRSN N/A
  • INDO N/A
  • P/E Ratio
  • MRSN N/A
  • INDO N/A
  • Revenue Growth
  • MRSN 16.14
  • INDO N/A
  • 52 Week Low
  • MRSN $5.21
  • INDO $2.10
  • 52 Week High
  • MRSN $70.75
  • INDO $7.95
  • Technical
  • Relative Strength Index (RSI)
  • MRSN 47.47
  • INDO 49.66
  • Support Level
  • MRSN $7.04
  • INDO $2.88
  • Resistance Level
  • MRSN $7.49
  • INDO $3.04
  • Average True Range (ATR)
  • MRSN 0.44
  • INDO 0.13
  • MACD
  • MRSN 0.00
  • INDO 0.01
  • Stochastic Oscillator
  • MRSN 36.53
  • INDO 25.00

About MRSN Mersana Therapeutics Inc.

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.

About INDO Indonesia Energy Corporation Limited

Indonesia Energy Corp Ltd is an oil and gas exploration and production company focused on Indonesia. The company is an independent energy company engaged in the oil and gas business and holds two oil and gas assets through its subsidiaries in Indonesia: The Kruh Block and the Citarum Block. It has also identified a potential third exploration block known as the Rangkas area. . Its portfolio consists of Kruh Block and Citarum Block. The company generates its revenue from oil and gas sales.

Share on Social Networks: